查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1588618

麻醉和呼吸設備市場規模、佔有率、趨勢分析報告：按產品、地區、細分市場預測，2025-2030 年

Anesthesia And Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Respiratory Devices (), Anesthesia Devices), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

麻醉和呼吸設備市場成長和趨勢：

Grand View Research, Inc.的最新報告顯示，預計2030年全球麻醉和呼吸設備市場規模將達到759億美元，2025年至2030年複合年成長率為5.9%。

呼吸系統疾病盛行率的增加、患者對縮短住院時間的偏好以及政府資助是關鍵促進因素。此外，老化被認為是導致睡眠呼吸中止症的最大風險因素之一，因此預計將成為該行業影響力較大的渲染促進因素。 COVID-19 大流行對該行業產生了重大影響。影響因細分市場而異。例如，由於機械人工呼吸器需求突然激增，人工呼吸器產業呈現快速成長。

但自2021年以來，這種需求有所下降，產業規模大幅萎縮。關於霧化器領域，由於使用吸入藥物，人們對使用霧化器感到擔憂，眾所周知，吸入藥物是病毒感染和免疫抑制的潛在原因。隨著患者偏好轉向縮短住院時間，麻醉和呼吸設備的採用增加預計將推動市場發展。根據美國醫院協會的數據，大約 20% 的醫療保險受益人在出院後 30 天內重新入院。識別和減少可避免的再入院有望改善醫療保健安全並減少支出。

因此，政策制定者正在努力減少病患住院時間。在《病患保護與負擔得起法案》中，國會於 2013 年啟動了醫院再入院減少計劃 (HRRP)，根據該計劃，醫療保險向再入院率高的醫院支付費用，現在可能會受到處罰。隨著該法的實施，許多醫生和患者開始選擇門診輸液幫浦和家用呼吸監視器等麻醉和呼吸設備。主要參與者正在努力開發先進設備以改善治療。例如，2022年5月，Max Ventilator推出了一款由內建加濕器和氧氣療法組成的非侵入性（NIV）人工呼吸器。該設備易於使用、重量輕，且成本低於傳統人工呼吸器。這些舉措預計將在未來幾年推動產業成長。

麻醉和呼吸設備市場報告亮點：

  • 就收益而言，由於慢性阻塞性肺病（COPD）、氣喘、結核病等盛行率不斷上升，呼吸設備業務在2024年佔據最大的收益佔有率。
  • 由於外科手術數量的增加以及市場參與企業的各種技術進步，預計麻醉設備領域在預測期內將顯著成長。
  • 由於該地區存在主要參與者，北美在 2024 年佔據了最大的收益佔有率。
  • 由於醫療保健支出的增加和患者意識的提高，預計亞太地區在預測期內將呈現最快的複合年成長率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章麻醉和呼吸設備市場變數、趨勢和範圍

  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
    • 市場機會
  • 麻醉和呼吸設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章麻醉和呼吸設備市場：產品估算和趨勢分析

  • 2023 年及 2030 年產品類型市場佔有率
  • 細分儀表板
  • 依產品類型
    • 麻醉裝置
    • 呼吸裝置

第5章麻醉和呼吸設備市場：按產品分類的區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場簡介
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2023年主要企業市場佔有率/地位分析
  • 公司簡介
    • General Electric Company
    • Medtronic
    • Teleflex Incorporated
    • Koninklijke Philips NV
    • Dragerwerk AG &CO. KGAA
    • Getinge AB
    • Smiths Group PLC
    • Fisher &Paykel Healthcare Limited
    • Masimo
    • Braun Melsungen AG
    • ResMed
    • Inogen, Inc.
    • Caire Medical（a subsidiary of NGK Spark Plug）
    • DeVilbiss Healthcare（a subsidiary of Drive Medical）
    • React Health（Respiratory Product Line from Invacare Corporation）
    • O2 Concepts
    • Nidek Medical Products, Inc.
    • Omron Corporation
    • GE Healthcare
    • Allied Healthcare
    • Vectura Group Plc.
    • PARI Respiratory Equipment, Inc.
    • Aerogen
    • DeVilbiss Healthcare LLC
    • Briggs Healthcare
    • Beurer GmBH
Product Code: 978-1-68038-557-1

Anesthesia And Respiratory Devices Market Growth & Trends:

The global anesthesia and respiratory devices market size is estimated to reach USD 75.9 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of respiratory diseases, patient preferences for a reduced hospital stay and supportive government funding are among the key driving factors. Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is, therefore, expected to be a high-impact rendering driver for this industry. The COVID-19 pandemic had a significant impact on the industry. Different segments were impacted differently. For instance, the ventilators segment witnessed exponential growth owing to the sudden surge in the demand for mechanical ventilators.

However, this demand decreased post-2021, wherein the industry size decreased dramatically. Concerning the nebulizers segment, people were apprehensive to use nebulizers owing to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression, which restricted the growth, but did not negatively impact the industry. Shifting the preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from the hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending.

Hence, policymakers are striving to reduce the hospital stays of patients. In the Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP), under which, Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors. Key players are taking initiatives to develop advanced instruments to bring improvement in the treatment. For instance, in May 2022, Max Ventilator launched Non-Invasive (NIV) ventilators consisting of inbuilt humidifiers and oxygen therapy. The device is user-friendly as well as lightweight and is also priced lower than the traditional ventilators. Such initiatives are anticipated to propel industry growth in the coming years.

Anesthesia And Respiratory Devices Market Report Highlights:

  • In terms of revenue, the respiratory devices segment held the largest revenue share in 2024, owing to the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and tuberculosis, among others
  • The anesthesia devices segment is expected to grow significantly over the forecast period, owing to the rising number of surgeries and various technological advancements by market players
  • North America accounted for the largest revenue share in 2024 owing to the presence of major players in the region
  • Asia Pacific is expected to witness the fastest CAGR during the forecast period owing to increasing healthcare expenditure and awareness among patients.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product outlook
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunities
  • 3.2. Anesthesia and Respiratory Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis

Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Brain Computer Interface Market by Product Type Outlook
    • 4.3.1. Anesthesia Devices
      • 4.3.1.1. Anesthesia Devices market estimates and forecasts, 2018 - 2030 (USD Million)
        • 4.3.1.1.1. Anesthesia Machines
          • 4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.2. Anesthesia Workstation
            • 4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.3. Anesthesia Delivery Station
            • 4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.1.1.1.3.2. Portable Anesthesia Delivery Station
      • 4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.1.1.1.3.3. Standalone Anesthesia Delivery Station
      • 4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.4. Anesthesia Ventilators
            • 4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.5. Anesthesia Monitors
            • 4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2018 - 2030 (USD Million)
        • 4.3.1.1.2. Anesthesia Disposables
          • 4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.2.2. Anesthesia Masks
            • 4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.2.3. Anesthesia Accessories
            • 4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Respiratory Devices
      • 4.3.2.1. Respiratory devices market estimates and forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Respiratory Equipment's
          • 4.3.2.1.1.1. Respiratory Equipment's market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.2. Humidifiers
            • 4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.2. Heat Humidifiers
      • 4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.3. Heated wire breathing circuits
      • 4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.4. Heat Exchangers
      • 4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.5. Pass Over Humidifiers
      • 4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.3. Nebulizers
            • 4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.3.2. Pneumatic nebulizers
      • 4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.3.3. Mesh nebulizers
      • 4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.3.4. Ultrasonic nebulizers
      • 4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.4. Oxygen Concentrators
            • 4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.4.2. Fixed Oxygen Concentrators
      • 4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.4.3. Portable Oxygen Concentrators
      • 4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.5. Positive airway pressure devices
            • 4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.5.2. Bi-level positive airway pressure devices
      • 4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.5.3. Continuous positive airway pressure devices
      • 4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.6. Reusable resuscitators
            • 4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.7. Ventilators
            • 4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.7.2. Adult Ventilators
      • 4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.7.3. Neonatal Ventilators
      • 4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.8. Respiratory inhalers
            • 4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.8.2. Dry Powdered Inhalers
      • 4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.8.3. Meter Dose Inhalers
      • 4.3.2.1.1.8.3.1. Meter Dose Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.9. Respiratory disposable
            • 4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.2. Disposable Oxygen Mask
      • 4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.3. Resuscitators
      • 4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.4. Tracheostomy Tubes
      • 4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.5. Oxygen Cannula
      • 4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.10. Respiratory measurement devices
            • 4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.2. Pulse oximetry systems
      • 4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.3. Capnographs
      • 4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.4. Spirometers
      • 4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.5. Peak flowmeters
      • 4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Mexico
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. France
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Italy
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Spain
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Norway
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.7. Sweden
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework/ reimbursement structure
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.8. Denmark
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework/ reimbursement structure
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework/ reimbursement structure
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework/ reimbursement structure
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework/ reimbursement structure
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework/ reimbursement structure
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework/ reimbursement structure
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Key company market share/position analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. General Electric Company
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Medtronic
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Teleflex Incorporated
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Koninklijke Philips N.V.
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Dragerwerk AG & CO. KGAA
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Getinge AB
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Smiths Group PLC
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Fisher & Paykel Healthcare Limited
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Masimo
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Braun Melsungen AG
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. ResMed
      • 6.4.11.1. Company Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic initiatives
    • 6.4.12. Inogen, Inc.
      • 6.4.12.1. Company Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic initiatives
    • 6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
      • 6.4.13.1. Company Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic initiatives
    • 6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical)
      • 6.4.14.1. Company Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic initiatives
    • 6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
      • 6.4.15.1. Company Overview
      • 6.4.15.2. Financial Performance
      • 6.4.15.3. Product Benchmarking
      • 6.4.15.4. Strategic initiatives
    • 6.4.16. O2 Concepts
      • 6.4.16.1. Company Overview
      • 6.4.16.2. Financial Performance
      • 6.4.16.3. Product Benchmarking
      • 6.4.16.4. Strategic initiatives
    • 6.4.17. Nidek Medical Products, Inc.
      • 6.4.17.1. Company Overview
      • 6.4.17.2. Financial Performance
      • 6.4.17.3. Product Benchmarking
      • 6.4.17.4. Strategic initiatives
    • 6.4.18. Omron Corporation
      • 6.4.18.1. Company Overview
      • 6.4.18.2. Financial Performance
      • 6.4.18.3. Product Benchmarking
      • 6.4.18.4. Strategic initiatives
    • 6.4.19. GE Healthcare
      • 6.4.19.1. Company Overview
      • 6.4.19.2. Financial Performance
      • 6.4.19.3. Product Benchmarking
      • 6.4.19.4. Strategic initiatives
    • 6.4.20. Allied Healthcare
      • 6.4.20.1. Company Overview
      • 6.4.20.2. Financial Performance
      • 6.4.20.3. Product Benchmarking
      • 6.4.20.4. Strategic initiatives
    • 6.4.21. Vectura Group Plc.
      • 6.4.21.1. Company Overview
      • 6.4.21.2. Financial Performance
      • 6.4.21.3. Product Benchmarking
      • 6.4.21.4. Strategic initiatives
    • 6.4.22. PARI Respiratory Equipment, Inc.
      • 6.4.22.1. Company Overview
      • 6.4.22.2. Financial Performance
      • 6.4.22.3. Product Benchmarking
      • 6.4.22.4. Strategic initiatives
    • 6.4.23. Aerogen
      • 6.4.23.1. Company Overview
      • 6.4.23.2. Financial Performance
      • 6.4.23.3. Product Benchmarking
      • 6.4.23.4. Strategic initiatives
    • 6.4.24. DeVilbiss Healthcare LLC
      • 6.4.24.1. Company Overview
      • 6.4.24.2. Financial Performance
      • 6.4.24.3. Product Benchmarking
      • 6.4.24.4. Strategic initiatives
    • 6.4.25. Briggs Healthcare
      • 6.4.25.1. Company Overview
      • 6.4.25.2. Financial Performance
      • 6.4.25.3. Product Benchmarking
      • 6.4.25.4. Strategic initiatives
    • 6.4.26. Beurer GmBH
      • 6.4.26.1. Company Overview
      • 6.4.26.2. Financial Performance
      • 6.4.26.3. Product Benchmarking
      • 6.4.26.4. Strategic initiatives

List of Tables

  • Table 1 North America Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 North America Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 3 U.S Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Canada Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Mexico Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Europe Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 Europe Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 UK Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Germany Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 France Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Italy Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Spain Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 Sweden Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 Denmark Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Norway Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 18 China Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Japan Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 India Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Australia Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 South Korea Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Thailand Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Brazil Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Argentina Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 MEA Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 29 MEA Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 South Africa Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Saudi Arabia Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 UAE Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 Kuwait Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Aesthesia and respiratory devices market outlook
  • Fig. 9 Aesthesia and respiratory devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Aesthesia and respiratory devices market driver impact
  • Fig. 15 Aesthesia and respiratory devices market restraint impact
  • Fig. 16 Aesthesia and respiratory devices market strategic initiatives analysis
  • Fig. 17 Aesthesia and respiratory devices market: Product movement analysis
  • Fig. 18 Aesthesia and respiratory devices market: Product outlook and key takeaways
  • Fig. 19 Anesthesia devices market, 2018 - 2030 (USD Million)
  • Fig. 20 Anesthesia delivery machines market, 2018 - 2030 (USD Million)
  • Fig. 21 Anesthesia monitors market, 2018 - 2030 (USD Million)
  • Fig. 22 Anesthesia ventilators market, 2018 - 2030 (USD Million)
  • Fig. 23 Anesthesia workstations market, 2018 - 2030 (USD Million)
  • Fig. 24 Anesthesia disposables market, 2018 - 2030 (USD Million)
  • Fig. 25 Anesthesia disposables masks market, 2018 - 2030 (USD Million)
  • Fig. 26 Anesthesia disposable accessories market, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Positive airway pressure market, 2018 - 2030 (USD Million)
  • Fig. 29 Ventilators market, 2018 - 2030 (USD Million)
  • Fig. 30 Nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 31 Humidifiers market, 2018 - 2030 (USD Million)
  • Fig. 32 Respiratory inhalers market, 2018 - 2030 (USD Million)
  • Fig. 33 Oxygen concentrators market, 2018 - 2030 (USD Million)
  • Fig. 34 Reusable resuscitators market, 2018 - 2030 (USD Million)
  • Fig. 35 Pulse oximeters market, 2018 - 2030 (USD Million)Anesthesia Devices
  • Fig. 36 Capnographs market, 2018 - 2030 (USD Million)
  • Fig. 37 Spirometers market, 2018 - 2030 (USD Million)
  • Fig. 38 Peak flow meters market, 2018 - 2030 (USD Million)
  • Fig. 39 Global aesthesia and respiratory devices market: Regional movement analysis
  • Fig. 40 Global aesthesia and respiratory devices market: Regional outlook and key takeaways
  • Fig. 41 Global anesthesia and respiratory devices market share and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America market estimates and forecasts, 2018 - 2030
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 59 France market estimates and forecasts, 2018 - 2030
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 66 China market estimates and forecasts, 2018 - 2030
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 68 India market estimates and forecasts, 2018 - 2030
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 76 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 78 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 80 Market share of key market players- Brain Computer Interface market
  • Fig. 81 Key Company Categorization
  • Fig. 82 Company Market Share/Position Analysis, 2023
  • Fig. 83 Strategic Framework